Clinical Trial Update: Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results assess the efficacy and safety of albiglutide for type 2 diabetes; the study completed with results posted in May 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tanzeum (Albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2014-05-16